The buzz surrounding generative artificial intelligence has reached a new milestone in the financial markets. While access to Anthropic capital remains closed to retail investors on traditional stock exchanges for now, the creator of the Claude model has officially set its regulatory plans in motion. By filing a confidential S-1 registration statement with the SEC in early June 2026, the California-based startup is laying the legal groundwork for an IPO that is already shaping up to be one of the most massive in the history of the tech sector.
The company's financial metrics have hit unprecedented heights for a private player. Bolstered by a record-breaking $65 billion Series H funding round, the firm boasts an estimated valuation of $965 billion, allowing it to temporarily surpass the valuation of its main rival, OpenAI. Under the guidance of major banking institutions such as Goldman Sachs, JPMorgan, and Morgan Stanley, preparatory meetings with institutional investors suggest a target market capitalization that could flirt with the $2 trillion mark during a potential Nasdaq listing in the fall of 2026.
Given the temporary lack of tradeable shares on regulated markets, alternative avenues have emerged within the decentralized ecosystem. Some traders have turned to pre-IPO derivatives markets or synthetic tokens to speculate on the firm's future value. However, these instruments carry major risks and provide no legal guarantees. The firm stance of Anthropic's management, disavowing the validity of any share transfers not authorized by its board of directors, triggered a more than 30% collapse in these tokenized assets, serving as a reminder that only the official opening of stock markets will confer true ownership rights.
Beyond the speculative frenzy, this move highlights the vital strategic trade-offs within the chip and algorithm sector. Backed financially by giants like Amazon and Google, the company is looking to secure its operational profitability in a climate of staggering infrastructure spending. Recent calls for a temporary slowdown in AI development, officially motivated by safety imperatives, could also serve to optimize the balance sheet, aiming to present attractive ratios when the final public prospectus is published.